Bio-Techne Corporation
IT ˙ BIT ˙ US09073M1045
54,00 € 0,00 (0,00%)
2026-06-03
AKTIENPREIS
SecurityIT:1TECH / Bio-Techne Corporation
InstitutionAristotle Atlantic Partners, Llc
Latest Disclosed Ownership612,826 shares
Latest Disclosed Value $ 32,026,286
Aristotle Atlantic Partners, Llc reports 3.77% decrease in ownership of 1TECH / Bio-Techne Corporation

On May 15, 2026 - Aristotle Atlantic Partners, Llc filed a 13F-HR form disclosing ownership of 612,826 shares of Bio-Techne Corporation (IT:1TECH) valued at $33,092,604 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 636,823 shares of Bio-Techne Corporation. This represents a change in shares of -3.77% during the quarter. The current value of the position is $33,092,604 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIO-TECHNE COM 09073M104 612,826 -23,997 -3.77 32,026 -14.49 0.8472
2026-02-17 2025-12-31 13F BIO-TECHNE COM 09073M104 636,823 -390,508 -38.01 37,452 -34.47 1.7134
2025-11-14 2025-09-30 13F BIO-TECHNE COM 09073M104 1,027,331 -24,946 -2.37 57,150 5.56 1.6579
2025-08-14 2025-06-30 13F BIO-TECHNE COM 09073M104 1,052,277 85,904 8.89 54,140 -4.45 1.6466
2025-05-15 2025-03-31 13F BIO-TECHNE COM 09073M104 966,373 212,011 28.10 56,658 4.27 1.9119
2025-02-14 2024-12-31 13F BIO-TECHNE COM 09073M104 754,362 -31,142 -3.96 54,337 -13.46 1.7084
2024-11-14 2024-09-30 13F BIO-TECHNE COM 09073M104 785,504 63,835 8.85 62,785 21.42 1.9520
2024-08-14 2024-06-30 13F BIO-TECHNE COM 09073M104 721,669 -14,090 -1.92 51,708 -0.16 1.6754
2024-05-15 2024-03-31 13F BIO-TECHNE COM 09073M104 735,759 -23,655 -3.11 51,790 -11.62 1.6904
2024-02-14 2023-12-31 13F BIO-TECHNE COM 09073M104 759,414 105,779 16.18 58,596 31.70 2.0621
2023-11-14 2023-09-30 13F BIO-TECHNE COM 09073M104 653,635 -8,579 -1.30 44,493 -17.69 1.7816
2023-08-14 2023-06-30 13F BIO-TECHNE COM 09073M104 662,214 139,028 26.57 54,057 39.27 2.0358
2023-05-15 2023-03-31 13F BIO-TECHNE COM 09073M104 523,186 -17 -0.00 38,815 -10.49 1.9961
2023-02-14 2022-12-31 13F BIO-TECHNE COM 09073M104 523,203 394,118 305.32 43,363 18.28 2.4288
2022-11-14 2022-09-30 13F BIO-TECHNE COM 09073M104 129,085 35,818 38.40 36,661 13.40 2.2302
2022-08-15 2022-06-30 13F BIO-TECHNE COM 09073M104 93,267 -3,758 -3.87 32,330 -23.05 2.4867
2022-05-16 2022-03-31 13F BIO-TECHNE COM 09073M104 97,025 1,428 1.49 42,016 -15.04 2.6002
2022-02-14 2021-12-31 13F BIO-TECHNE COM 09073M104 95,597 4,445 4.88 49,456 11.97 2.8710
2021-11-15 2021-09-30 13F BIO-TECHNE COM 09073M104 91,152 1,050 1.17 44,169 8.87 2.9226
2021-08-16 2021-06-30 13F BIO-TECHNE COM 09073M104 90,102 1,095 1.23 40,569 19.34 2.6759
2021-05-17 2021-03-31 13F BIO-TECHNE COM 09073M104 89,007 2,014 2.32 33,995 23.06 2.4860
2021-02-16 2020-12-31 13F BIO-TECHNE COM 09073M104 86,993 -4,669 -5.09 27,625 21.65 2.1318
2020-11-16 2020-09-30 13F BIO-TECHNE COM 09073M104 91,662 1,038 1.15 22,708 -5.11 2.0003
2020-08-14 2020-06-30 13F BIO-TECHNE COM 09073M104 90,624 15,600 20.79 23,931 68.22 2.2987
2020-05-14 2020-03-31 13F BIO-TECHNE COM 09073M104 75,024 -10,487 -12.26 14,226 -24.21 2.1727
2020-02-13 2019-12-31 13F BIO TECHNE COM 09073M104 85,511 52,534 159.30 18,771 190.93 2.3971
2019-11-14 2019-09-30 13F BIO TECHNE COM 09073M104 32,977 1,045 3.27 6,452 -3.09 1.8581
2019-08-13 2019-06-30 13F BIO TECHNE COM 09073M104 31,932 1,425 4.67 6,658 9.92 1.9357
2019-05-15 2019-03-31 13F BIO TECHNE COM 09073M104 30,507 1,330 4.56 6,057 43.43 1.8405
2019-02-13 2018-12-31 13F BIO TECHNE COM 09073M104 29,177 8,147 38.74 4,223 2.43 1.4883
2018-11-14 2018-09-30 13F BIO TECHNE COM 09073M104 21,030 -6,080 -22.43 4,123 2.87 2.5199
2018-08-14 2018-06-30 13F BIO TECHNE COM 09073M104 27,110 17,110 171.10 4,008 165.43 1.3898
2018-09-07 2018-03-31 13F/A-1 BIO TECHNE COM 09073M104 10,000 10,000 1,510 0.5450
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.